B – Current evidence indicates that anti-Kell antibodies suppress fetal erythropoiesis but do not inhibit megakaryocyte progenitors; studies therefore show no association between maternal Kell alloimmunization and fetal thrombocytopenia [Vaughan, 1998, PMID 9504940].